A carregar...

Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanib

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic lung disease with no clear etiology and a paucity of therapeutic options. Nintedanib (previously known as BIBF 1120) is a tyrosine kinase receptor antagonist which inhibits a number of key receptors, including those for platelet...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Woodcock, Hannah V, Molyneaux, Philip L, Maher, Toby M
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3693725/
https://ncbi.nlm.nih.gov/pubmed/23818761
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S38833
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!